Theriva Biologics, Inc. (TOVX) Description, Stock price, News & Info

#ThinkSabio Latest News

$TOVX Theriva Biologics Announces Presentation of Data from the Phase 1b/2a Clinical Trial of SYN-004 (ribaxamase) in Allogeneic Hematopoietic Cell Transplant Recipients